Amgen seems to be receiving attention in the market, with numerous entities buying or trimming their stock holdings. SVB Wealth LLC and Advisor OS LLC are two organizations known to have acquired a new stake in the firm. Despite some mixed movement, the firm has been recognized as one of the best performing Dow stocks so far in 2025. The company showed significant financial results in Q4 and the full year of 2024. Jim Cramer of Blockbuster Drugs stated that it's absurd for the stock to sells at 14x earnings, expressing value in it. The company's R&D Chief will likely talk about new breakthroughs at the upcoming Healthcare Conference. The firm is also garnering attention for investing $200M in an AI technology center in India, leading to technological advancements. The recently published earnings estimates have been positively adjusted by Zacks Research Brokers.
Amgen AMGN News Analytics from Wed, 30 Oct 2024 07:00:00 GMT to Sat, 01 Mar 2025 13:13:09 GMT -
Rating 8
- Innovation 2
- Information 7
- Rumor 3
